Compounds > beta-solamarine
Page last updated: 2024-09-05

beta-solamarine and epirubicin

beta-solamarine has been researched along with epirubicin in 3 studies

Compound Research Comparison

Studies
(beta-solamarine)		Trials
(beta-solamarine)		Recent Studies (post-2010)
(beta-solamarine)		Studies
(epirubicin)		Trials
(epirubicin)		Recent Studies (post-2010) (epirubicin)
632385,4531,8381,570

Protein Interaction Comparison

ProteinTaxonomybeta-solamarine (IC50)epirubicin (IC50)
Genome polyprotein 0.75
Tyrosine-protein kinase FynHomo sapiens (human)5.181

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, LC; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY1
Chang, LC; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY; Tsai, EM2

Other Studies

3 other study(ies) available for beta-solamarine and epirubicin

ArticleYear
Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells.
    Molecular nutrition & food research, 2007, Volume: 51, Issue:8

    Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; DNA Topoisomerases, Type II; DNA-Binding Proteins; Down-Regulation; Drug Synergism; Epirubicin; fas Receptor; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lung Neoplasms; Poly-ADP-Ribose Binding Proteins; RNA, Messenger; Solanaceous Alkaloids; Up-Regulation

2007
Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin.
    Chemical research in toxicology, 2008, Volume: 21, Issue:2

    Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lung Neoplasms; Poly-ADP-Ribose Binding Proteins; Solanaceous Alkaloids; Trastuzumab; Up-Regulation

2008
Solamargine induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of HER2/neu.
    Bioscience reports, 2009, Volume: 29, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Epirubicin; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Solanaceous Alkaloids; Trastuzumab

2009